Juniper Pharma Reports Publication of Phase 1 Study Showing Ability of IVR to Deliver Large Molecules
May 05, 2016 at 11:58 AM EDT
Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced that ...
